SyNoesis Therapeutics is a start-up biotech with the vision to cure Parkinson's disease (PD) and other major brain diseases. We aim to capitalize on the potential of a new therapeutic we have patented for PD to be further developed towards being successful in clinical trials and become the first drug to cure it.
The therapeutic shows multi-acting efficacy and covers at the same time the major unmet needs of PD in several mouse models and has drug-like properties. We filed a PCT application and we are expressed funding interest by big pharmas. We have now begun our regulatory trials towards clinical trials....
SyNoesis Therapeutics is a start-up biotech with the vision to cure Parkinson's disease (PD) and other major brain diseases. We aim to capitalize on the potential of a new therapeutic we have patented for PD to be further developed towards being successful in clinical trials and become the first drug to cure it.
The therapeutic shows multi-acting efficacy and covers at the same time the major unmet needs of PD in several mouse models and has drug-like properties. We filed a PCT application and we are expressed funding interest by big pharmas. We have now begun our regulatory trials towards clinical trials.
More information

Employees

Athanasios Spathis
Admin
Athanasios Spathis CEO passion for innovtion for top health unmet needs, determined motivation, father and husband